117
Participants
Start Date
March 8, 2019
Primary Completion Date
October 12, 2023
Study Completion Date
October 12, 2023
Mosunetuzumab
Participants will receive intravenous (IV) mosunetuzumab.
Polatuzumab Vedotin
Participants will receive polatuzumab vedotin via IV.
Rituxumab
Participants will receive rituxumab via IV.
Cyclophosphamide
Participants will receive cyclophosphamide via IV.
Doxorubicin
Participants will receive doxorubicin via IV.
Vincristine
Participants will receive vincristine via IV.
Prednisone
Participants will receive oral prednisone.
Tocilizumab
Participants will receive tocilizumab via IV.
Medizinische Universität Wien, Allgemeines Krankenhaus der Stadt Wien, Vienna
Hanusch-Krankenhaus, Vienna
LKH Steyr, Steyr
Uniklinikum Salzburg, LKH; Univ.Klinik f. Innere Medizin III der PMU, Salzburg
Hospital de la Santa Creu i Sant Pau, Barcelona
Hospital San Pedro de Alcantara; Servicio de Hematología, Cáceres
Georgetown University Medical Center, Washington D.C.
Hospital General Universitario Gregorio Marañon, Madrid
Hospital Universitario 12 de Octubre, Madrid
Hospital Universitario La Paz, Madrid
Clinica Universidad de Navarra, Pamplona
University of Miami Miller School of Medicine, Miami
University of Alabama Birmingham, Birmingham
Vanderbilt University Medical Center, Nashville
Hospital Universitario Virgen Macarena, Seville
Centre Henri Becquerel- Centre de Lutte Contre le Cancer, Saint-Herblain
University of Michigan, Ann Arbor
Pusan National University Yangsan Hospital, Gyeongsangnam-do
Mayo Clinic Cancer Center, Rochester
University of Kansas Cancer Center, Westwood
Centre Leon Berard, Lyon
Hôpital Saint-Louis, Paris
Scott and White Hospital; Cancer Center, Temple
Banner MD Anderson Cancer Center, Gilbert
University of California; Moores Cancer Center, La Jolla
CHU Henri Mondor; Service d'Oncologie Medicale, Créteil
Gustave Roussy, Villejuif
University of California, Los Angeles (UCLA) - Hematology/Oncology Santa Monica, Santa Monica
Dana-Farber Cancer Institute, Boston
Rhode Island Hospital, Providence
The University of Texas MD Anderson Cancer Center, Houston
Medical College of Wisconsin, Inc., Milwaukee
Maria Sklodowska-Curie Memorial Cancer Centre, Gliwice
Ma?opolskie Centrum Medyczne, Krakow
Wojewodzki Szpital Specjalistyczny im. Janusza Korczaka, Słupsk
Instytut Hematologii i Transfuzjologii; Klinika Zaburze? Hemostazy i Chorób Wewn?trznych, Warsaw
Katedra i Klinika Hematologii; Nowotworów Krwi i Transplantacji Szpiku, Wroc?aw
Seoul National University Hospital, Seoul
Asan Medical Center, Seoul
Samsung Medical Center, Seoul
Institut Catala d?Oncologia Hospital Germans Trias i Pujol, Badalona
Hoffmann-La Roche
INDUSTRY